Latest News

Flu hospitalizations drop amid signs of an early peak


 

It’s beginning to look less like an epidemic as seasonal flu activity “appears to be declining in some areas,” according to the Centers for Disease Control and Prevention.

Declines in a few states and territories were enough to lower national activity, as measured by outpatient visits for influenza-like illness, for the second consecutive week. This reduced the weekly number of hospital admissions for the first time in the 2022-2023 season, according to the CDC influenza division’s weekly FluView report.

Proportion of outpatient visits for influenza-like illness by week

Flu-related hospital admissions slipped to about 23,500 during the week of Dec. 4-10, after topping 26,000 the week before, based on data reported by 5,000 hospitals from all states and territories.

The weekly hospitalization rate tumbled from 8 per 100,000 people to 4.5 per 100,000, which was still higher than any other December rate from all previous seasons going back to 2009-10, CDC data shows.

Visits for flu-like illness represented 6.9% of all outpatient visits reported to the CDC during the week of Dec. 4-10. The rate reached 7.5% during the last full week of November before dropping to 7.3%, the CDC said.

There were 28 states or territories with “very high” activity for the latest reporting week, compared with 32 the previous week. Eight states – Colorado, Idaho, Kentucky, Nebraska, New Mexico, Oklahoma, Tennessee, and Washington – and New York City were at the very highest level on the CDC’s 1-13 scale of activity, compared with 14 areas the week before, the agency reported.

So far for the 2022-2023 season, the CDC estimated there have been at least 15 million cases of the flu, 150,000 hospitalizations, and 9,300 deaths. Among those deaths have been 30 reported in children, compared with 44 for the entire 2021-22 season and just 1 for 2020-21.

A version of this article first appeared on WebMD.com.

Recommended Reading

Buzzy Lancet long COVID paper under investigation for ‘data errors’
Clinician Reviews
RSV surge stuns parents and strains providers, but doctors offer help
Clinician Reviews
FDA pulls U.S. authorization for Eli Lilly’s COVID drug bebtelovimab
Clinician Reviews
Study comparing surgical and N95 masks sparks concern
Clinician Reviews
Children and COVID: Hospitalizations provide a tale of two sources
Clinician Reviews
Paxlovid has been free so far. Next year, sticker shock awaits
Clinician Reviews
How a cheap liver drug may be the key to preventing COVID
Clinician Reviews
As COVID treatments dwindle, are new ones waiting in the wings?
Clinician Reviews
U.S. sees most flu hospitalizations in a decade
Clinician Reviews
HIV vaccine trial makes pivotal leap toward making ‘super antibodies’
Clinician Reviews